Departamento de Ciencias Biomédicas-Fisiología, Facultad de Veterinaria, Universidad de León, León, Spain.
Instituto de Desarrollo Ganadero y Sanidad Animal (INDEGSAL), Universidad de León, León, Spain.
Antimicrob Agents Chemother. 2023 May 17;67(5):e0009523. doi: 10.1128/aac.00095-23. Epub 2023 Apr 20.
Clorsulon is a benzenesulfonamide drug that is effective in treating helminthic zoonoses such as fascioliasis. When used in combination with the macrocyclic lactone ivermectin, it provides high broad-spectrum antiparasitic efficacy. The safety and efficacy of clorsulon should be studied by considering several factors such as drug-drug interactions mediated by ATP-binding cassette (ABC) transporters due to their potential effects on the pharmacokinetics and drug secretion into milk. The aim of this work was to determine the role of ABC transporter G2 (ABCG2) in clorsulon secretion into milk and the effect of ivermectin, a known ABCG2 inhibitor, on this process. Using transepithelial assays with cells transduced with murine Abcg2 and human ABCG2, we report that clorsulon was transported by both transporter variants and that ivermectin inhibited its transport mediated by murine Abcg2 and human ABCG2. Wild-type and Abcg2 lactating female mice were used to carry out assays. The milk concentration and the milk-to-plasma ratio were higher in wild-type mice than in Abcg2 mice after clorsulon administration, showing that clorsulon is actively secreted into milk by Abcg2. The interaction of ivermectin in this process was shown after the coadministration of clorsulon and ivermectin to wild-type and Abcg2 lactating female mice. Treatment with ivermectin had no effect on the plasma concentrations of clorsulon, but the milk concentrations and milk-to-plasma ratios of clorsulon decreased in comparison to those with treatment without ivermectin, only in wild-type animals. Consequently, the coadministration of clorsulon and ivermectin reduces clorsulon secretion into milk due to drug-drug interactions mediated by ABCG2.
氯舒隆是一种苯磺酰胺类药物,对 Fascioliasis 等动物源性人兽共患寄生虫病具有良好疗效。当与大环内酯类伊维菌素联合使用时,具有高效广谱抗寄生虫作用。考虑到药物-药物相互作用,即 ABC 转运蛋白(ABC)介导的药物-药物相互作用,可能会影响药物的药代动力学和向乳汁中的分泌,氯舒隆的安全性和有效性应该进行研究。ABC 转运蛋白 G2(ABCG2)在氯舒隆向乳汁中分泌中的作用以及伊维菌素(一种已知的 ABCG2 抑制剂)对该过程的影响。使用转染了鼠 Abcg2 和人 ABCG2 的细胞的跨上皮测定法,我们报告氯舒隆被这两种转运蛋白变体转运,伊维菌素抑制了其介导的鼠 Abcg2 和人 ABCG2 的转运。使用野生型和 Abcg2 泌乳雌性小鼠进行测定。氯舒隆给药后,野生型小鼠的乳汁浓度和乳汁-血浆比高于 Abcg2 小鼠,表明氯舒隆通过 Abcg2 主动分泌到乳汁中。在向野生型和 Abcg2 泌乳雌性小鼠同时给予氯舒隆和伊维菌素后,显示出伊维菌素在该过程中的相互作用。伊维菌素治疗对氯舒隆的血浆浓度没有影响,但与不给予伊维菌素治疗相比,仅在野生型动物中,氯舒隆的乳汁浓度和乳汁-血浆比降低。因此,氯舒隆和伊维菌素的联合给药由于 ABCG2 介导的药物-药物相互作用而减少氯舒隆向乳汁中的分泌。